Article
Real-world incidence of febrile neutropenia despite primary prophylaxis with pegylated G-CSF: a prospective single centre cohort study from India
2026-01-21
Abstract excerpt
<title>Abstract</title> <p>Background Contemporary trials report febrile neutropenia (FN) rates of 1–2% with primary pegylated G-CSF prophylaxis, but real-world outcomes from low- and middle-income countries (LMICs) remain poorly documented, especially regarding the role and impact of rescue short-acting G-CSF after breakthrough FN. Methods Prospective single-arm cohort study (CTRI/2024/09/073887) of 125 adult...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89d8d741-b4ae-5a84-853f-5fbbee78c714
- DOI
- 10.21203/rs.3.rs-8417000/v1
